Safety of reproduced pharmaceuticals and legal issues of their circulation in Russia
Due to restrictions on importing medicines from abroad, the domestic pharmaceutical industry is shifting its focus towards the development and manufacturing generic drugs - medications containing a pharmacological substance identical to the original (previously patented/registered). However, the iss...
Saved in:
| Main Authors: | Alexander V. Savoskin, Vitaly A. Rukoleev |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Peoples’ Friendship University of Russia (RUDN University)
2024-12-01
|
| Series: | RUDN Journal of Law |
| Subjects: | |
| Online Access: | https://journals.rudn.ru/law/article/viewFile/41935/24173 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biowaiver based on biopharmaceutics classification system: Considerations and requirements
by: Pratik R. Dhake, et al.
Published: (2024-12-01) -
Therapeutic monitoring of pediatric transplant patients with conversion to generic tacrolimus
by: Natalia Riva, et al.
Published: (2017-03-01) -
Therapeutic drug monitoring of atypical antipsychotic drugs
by: Grundmann Milan, et al.
Published: (2014-12-01) -
Unveiling the Potential of C<sub>max</sub> <i>f</i><sub>2</sub> Factor Applied to Pilot Bioavailability/Bioequivalence Studies—A Case Study with Pazopanib Drug Products
by: Sara Carolina Henriques, et al.
Published: (2024-12-01) -
A review of new drugs approved by the food and drug administration in 2022
by: Arjun Swaminathan, et al.
Published: (2023-10-01)